Prognostic Impact of Genetic Polymorphism in Mineralocorticoid Receptor and Comorbidity With Hypertension in Androgen-Deprivation Therapy-Reference-Cited by-同舟云学术

Prognostic Impact of Genetic Polymorphism in Mineralocorticoid Receptor and Comorbidity With Hypertension in Androgen-Deprivation Therapy

Published:2018-12-18 Issue: Volume:8 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Shiota Masaki,Fujimoto Naohiro,Imada Kenjiro,Kashiwagi Eiji,Takeuchi Ario,Inokuchi Junichi,Tatsugami Katsunori,Kajioka Shunichi,Uchiumi Takeshi,Eto Masatoshi

Funder

Japan Society for the Promotion of Science

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference20 articles.

1. Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer;Shiota;Int J Urol,2016

2. Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target;Shiota;J Mol Endocrinol,2011

3. Pro-survival and anti-apoptotic properties of androgen receptor signaling by oxidative stress promote treatment resistance in prostate cancer;Shiota;Endocr Relat Cancer,2012

4. Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade;Arora;Cell,2013

5. Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer;Isikbay;Horm Cancer,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive model of castration resistance in advanced prostate cancer by machine learning using genetic and clinical data: KYUCOG-1401-A study;BJC Reports;2024-09-09

2. Genetic Profiling of Glucocorticoid (NR3C1) and Mineralocorticoid (NR3C2) Receptor Polymorphisms before Starting Therapy with Androgen Receptor Inhibitors: A Study of a Patient Who Developed Toxic Myocarditis after Enzalutamide Treatment;Biomedicines;2022-05-29

3. Genetic Polymorphisms and Pharmacotherapy for Prostate Cancer;JMA Journal;2021

4. Prognostic significance of antihypertensive agents in men with castration-resistant prostate cancer;Urologic Oncology: Seminars and Original Investigations;2019-11

5. The Role of Nuclear Receptors in Prostate Cancer;Cells;2019-06-17